Today I have an exciting position in Ondas Holdings $ONDS (+3,62%) a company that specializes in autonomous autonomous drone systems and mission-critical networks specialized in autonomous drone systems and mission-critical networks. The combination of innovative technology and growing demand for security and infrastructure solutions makes Ondas a real growth champion. I came across the share myself via Getquin.

💡 Why Ondas?

• Focus on autonomous drones and counter-drone systems
• Strong order backlog and growing sales in the drone segment
• Potential to establish itself as a leading provider in niche markets for authorities, defense and critical infrastructure

🔮 Future prospects:

• Further government and industrial orders could greatly accelerate growth
• Expansion of production and service capacities, also internationally
• Possible in the long term: combination of network and drone technologies as complete solutions for mission-critical applications

Important: Ondas combines several relevant areas: not only drones, but also networks + counter-drone. This allows it to offer complete solutions, which some competitors lack, e.g. focusing only on detection or only on hardware.

📈 I see the investment as a growth opportunitythat fits ideally into a diversified portfolio. This alongside $PNG (-2,35%) 🐙 and $CV 💊

#wachstumsaktien
#drohnen
#innovation
#technologie
#missioncritical
#investieren
#aktienliebe
#futuretech
#investieren
#börse
#usa
#deutschland
#nasdaq
#smallcap
#aktien
#technologie
#aktie

On 18.07. I bought shares in CapsoVision at USD 4.76 $CV in my portfolio.

The reason: the company is working on approval of its colon capsule - a product with great market potential in the field of capsule endoscopy. In the IPO prospectus and in analysts' comments, the colon market was described as having greater market potential than the current small intestine segment.

I have calculated three scenarios (example with 1000 shares):

🔹 Conservative (~6 USD): approx. 6,000 USD (+1.2k profit)

🔹 Moderate (~13.5 USD): Approx. 13,500 USD (+8.7k profit)

🔹 Aggressive (~30 USD): Approx. 30,000 USD (+25.2k profit)

Of course, this is not a guarantee, but a look at opportunities that could arise if CapsoVision makes the breakthrough.

👉 It will be particularly exciting to see how quickly the technology is accepted in practice and whether the colon capsule really changes the market.

What do you think? Gamechanger in MedTech or too much risk?

#aktien
#medtech
#wachstumsaktien
#capsovision
#investieren
#longterm
#chancen
#gesundheit
#getquin
#innovation
#börse
#dax
#nyse
#nasdaq
#invest
#medical
#medizin
#tenbagger
#aktie

Today, two companies in particular catch the eye - both with price movements that have taken off and are arousing curiosity:

🔹 CapsoVision $CV

• Share price today: around USD 4.63 - with a decent jump compared to the last few days.
• The price has managed to hold above important support zones and seems to be building momentum. Technically, this suggests that the previous downward or sideways trend could turn into a bullish phase.

🔹 Kraken Robotics $PNG (-2,35%)

• Also with a noticeable plus today: the price rose in CAD to approx. CAD 4.58 and gained over +8 % up.
• The stock is showing noticeable movement, with a stable structure and growing interest, not to mention the great margins.

Both stocks today show that it is possible for momentum to develop - and not just in small steps, but with visible momentum. Such movements can often be the trigger for broader market attention or further positive reactions. If volume and sentiment continue to stabilize, such a movement can become more.

Are you already invested in one of these stocks?

#investieren
#aktien
#aktie
#deutschland
#usa
#tech
#etf
#rendite
#börse
#getquin
#invest
#stockanalysis
#nasdaq
#nyse
#dax
#investing
#profit
#stock
#stocks
#bitcoin
#ethereum
#krypto
#international
#comment

Strong start to the week: A clear upward trend, especially between Monday and Wednesday, when the price rose from ~4.33 to ~4.63 USD.

The price seems to be in a positive momentum - could indicate that market participants are becoming more optimistic.

Analysts rate with price targets above current levels, which could be further upside potential.

Who of you is also invested? 🚀

$CV

#aktien
#investing
#capsoVision
#rendite
#wachstum
#börsennews
#smallcaps
#trading
#wochenrückblick
#finanzwissen
#anleger
#börsentalk
#investieren
#etfs
#börse

On August 27, CapsoVision $CV announced that CFO Kevin Lundquist is stepping down. Importantly, he will remain with the company as a consultant until the end of February 2026 - a clearly regulated transition.

🔎 What does this mean for the share?

• Such CFO changes often lead to uncertainty in the short term, sometimes with -1 to -3 % share price movement.
• In the long term, however, the effects are usually neutral - the decisive factor is that the business and the product pipeline remain intact.
• In the case of CapsoVision, the decisive catalysts continue to be the 510(k) approval of the Colon capsule (2026) and the planned AI modules.

👉 For me, this is more of a small interim announcementnot a game changer. The story remains exciting, as the market launch of the Colon capsule holds the real upside potential.

How do you see it? Do you react to CFO changes with sales - or do you remain relaxed and invested in such news? 💭

#CapsoVision
#MedTech
#SmallCapStocks
#GrowthStocks
#IPO2025
#FDAApproval
#InvestmentCommunity
#invest
#aktien

📈 New purchase - CapsoVision

I am with CapsoVision
$CV an innovative MedTech company that is setting new standards with its 360° capsule endoscopy. No external recorder required, full perspective - and already FDA-approved & in use in the USA.

💡 Why this investment?

• Technological advantage compared to traditional solutions (e.g. PillCam from Medtronic)
• Already cooperating with Pentax Medical
• Focus on early detection & diagnosticsa megatrend in the healthcare sector
• Low market capitalization (~180m USD) with a lot of upside potential

🚀 Vision:

If CapsoVision reaches USD 50-100m sales in the medium term, a multiple in the share price is possible. In the long term I see 10-25 USD+ per share as realistic - depending on market penetration and access to capital, of course.

I think: exciting small cap story with disruptive potential - What do you think?

👉 Do you know the company? How do you rate the opportunities & risks?

Please leave your opinion!

#aktien
#investieren
#MedTech
#CapsoVision
#SmallCap
#langfristig
#innovation
#getquin
#medizin
#medizintechnik
#pharma
#medical
#zukunft
$NOVO B (+0,13%)
$PLTR (+2,29%)
$AMD (+6,32%)
$NOVN (-0,92%)

Hey community 👋 do you already know CapsoVision Inc.a newly listed MedTech company with a focus on capsule endoscopy and AI-supported diagnostics?

The company is developing capsules that patients can swallow to examine the small intestine or, in future, the large intestine -> non-invasively.

This capsule is approved worldwide, wireless incl. 360° panorama.

IPO was completed on July 3, 2025.

Some figures:

Turnover (TTM) approx. USD 12 million

YoY growth +38 %

Gross margin 63 %

Loss (TTM) approx. USD -21 million

EV/Sales approx. 16×

Cash after IPO ~26m USD

Of course, this is not a dividend stock - high losses, high expectations, but also:

✅ Real product on the market

✅ Innovation with AI potential

✅ Good gross margin & sales growth

✅ Just went public → plenty of room for discovery

👉 I'm curious to see whether CapsoVision will become a success story à la "MedTech Hidden Champion" in 2-3 years - or whether it will remain an attempt.

What do you think?

$CV
#ipo
#medtech
#medizin
#health
#gesundheit
#aktie
#nasdaq
#medical
#gesund
#pharma
#international
#getquin
#deutschland
#österreich
#schweiz
#usa